Innovent Biologics and Sanegene Bio USA have entered a collaboration to co-develop SGB-3908, an siRNA drug candidate targeting angiotensinogen (AGT) for hypertension treatment. SGB-3908, an IND-e...
Singapore-based pharmaceutical company, Juniper Biologics, has been awarded the prestigious title of "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP)...
